Does SITAGLIPTIN Cause Hyperlipidaemia? 186 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Hyperlipidaemia have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.9% of all adverse event reports for SITAGLIPTIN.
186
Reports of Hyperlipidaemia with SITAGLIPTIN
0.9%
of all SITAGLIPTIN reports
137
Deaths
171
Hospitalizations
How Dangerous Is Hyperlipidaemia From SITAGLIPTIN?
Of the 186 reports, 137 (73.7%) resulted in death, 171 (91.9%) required hospitalization, and 49 (26.3%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 186 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
METOPROLOL (138)
Which SITAGLIPTIN Alternatives Have Lower Hyperlipidaemia Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE